Article

An American Journal of Managed Care® Symposium: Examining Treatment Advancements in Psoriasis and Psoriatic Arthritis

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Steven Daveluy, MD, dermatologist, Wayne State University
April Armstrong, MD, MPH, chief of dermatology, UCLA
April Armstrong, MD, MPH, chief of dermatology, UCLA
Related Content
Psoriasis treatment concept | Sviatlana - stock.adobe.com
August 20th 2025

Beyond the Surface: How New Therapies, Patient-Centered Care Are Changing Psoriasis Outcomes

Pearl Steinzor
Psoriasis as an Inflammatory Disease, and What’s Changed Over Time
August 20th 2025

Psoriasis as an Inflammatory Disease, and What’s Changed Over Time

Psoriasis in older woman | Image credit: ajr_images - stock.adobe.com
August 20th 2025

Tildrakizumab Found Effective, Safe in Elderly Patients With Psoriasis

Pearl Steinzor
Biosimilars. | Image Credit: Shutter2U - stock.adobe.com
August 20th 2025

Switching Biologics in Psoriasis Boosts Effectiveness but Raises Infection Risk

Pearl Steinzor
Family planning/consult | Image credit: Satori Studio - stock.adobe.com
August 20th 2025

Patients With Psoriasis Seek Better Family Planning Guidance

Pearl Steinzor
Apremilast | luchschenF - stock.adobe.com
August 20th 2025

Apremilast Maintains Efficacy at 2 Years in Pediatric Psoriasis

Pearl Steinzor

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo